Advanced search
Publication Cover
International Journal of General Medicine Volume 14, 2021 - Issue
Submit an article Journal homepage
210
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Real-World Effectiveness and Safety of Apixaban versus Warfarin in Patients with Acute Venous Thromboembolism: Experience of a Large Tertiary Hospital in Saudi Arabia

Majed S Al Yami1 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia;2 King Abdullah International Medical Research Center, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-2308-8407View further author information
ORCID Icon,
Mohammed Y Alzahrani1 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia;2 King Abdullah International Medical Research Center, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-4291-2959View further author information
ORCID Icon,
Abdulmajeed M Alshehri1 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia;2 King Abdullah International Medical Research Center, Riyadh, Saudi ArabiaView further author information
,
Omar A Alshaya1 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia;2 King Abdullah International Medical Research Center, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-2244-0491View further author information
ORCID Icon,
Norah S Alsubiae1 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaView further author information
,
Yazeed M Alharbi1 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaView further author information
,
Latifah K Albaiahy1 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaView further author information
,
Mounira Aldeiban1 Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaView further author information
,
Haya A Alkuait3 Sales Department, SPIMACO Addwaeih, Riyadh, Saudi ArabiaView further author information
,
Wejdan Alobaidi4 Sales Department,Novo Nordisk, Riyadh, Saudi ArabiaView further author information
,
Anas Aldawsari5 Sales Department,Sanofi, Riyadh, Saudi ArabiaView further author information
,
Nouf M Almutairi6 Sales Department, BAYER Pharmaceutical, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-5162-5241View further author information
ORCID Icon,
Mohannad Alshibani7 Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-3997-676XView further author information
ORCID Icon,
Ghazwa B Korayem8 Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi ArabiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2022-5955View further author information
ORCID Icon,
Osamah M Alfayez9 Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi ArabiaView further author information
,
Abdulaali R Almutairi10 Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi ArabiaView further author information
&
Omar A Almohammed11 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-3792-4106View further author information
ORCID Icon show all
Pages 4031-4037 | Published online: 28 Jul 2021

References

  • Mahan CE, Borrego ME, Woersching AL, et al. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost. 2012;108(08):291–302. doi:10.1160/TH12-03-0162
  • Stone J, Hangge P, Albadawi H, et al. Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S276–S284. doi:10.21037/cdt.2017.09.01
  • Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–4738. doi:10.1182/bloodadvances.2020001830
  • Quante M, Thate-Waschke I, Schofer M. [What are the reasons for patient preference? A comparison between oral and subcutaneous administration]. Z Orthop Unfall. 2012;150(4):397–403. (German). doi:10.1055/s-0031-1298347
  • Wong A, Kraus PS, Lau BD, et al. Patient preferences regarding pharmacologic venous thromboembolism prophylaxis. J Hosp Med. 2015;10(2):108–111. doi:10.1002/jhm.2282
  • Bishop L, Young S, Twells L, Dillon C, Hawboldt J. Patients’ and physicians’ satisfaction with a pharmacist managed anticoagulation program in a family medicine clinic. BMC Res Notes. 2015;8:233. doi:10.1186/s13104-015-1187-8
  • U.S. Food and Drug Administration (U.S. FDA). Pradaxa; 2010. Available from: www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022512Orig1s000TOC.cfm. Accessed April 20, 2021.
  • Julia S, James U. Direct oral anticoagulants: a quick guide. Eur Cardiol. 2017;12(1):40–45. doi:10.15420/ecr.2017:11:2
  • Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369(9):799–808. doi:10.1056/NEJMoa1302507
  • Booth CM, Tannock IF. Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer. 2014;110(3):551–555. doi:10.1038/bjc.2013.725
  • Cullell N, Carrera C, Muiño E, Torres N, Krupinski J, Fernandez-Cadenas I. Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants. Oncotarget. 2018;9(49):29238–29258. doi:10.18632/oncotarget.25579
  • Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694. doi:10.1111/j.1538-7836.2005.01204.x
  • Griffin BA, McCaffrey DF, Burgette LF, et al. Coffman, State-of-the-Art Strategies for Addressing Selection Bias When Comparing Two or More Treatment Groups. Santa Monica, CA: RAND Corporation; 2020. Available from: https://www.rand.org/pubs/conf_proceedings/CF421.html.
  • Griffin BA, Sanchez R, Cefalu M, et al. Toolkit for Weighting and Analysis of Nonequivalent Groups: A Tutorial on the TWANG Shiny App for Two Treatments. Santa Monica, CA: RAND Corporation; 2020. Available from: https://www.rand.org/pubs/tools/TLA570-2.html.
  • Dawwas GK, Smith SM, Dietrich E, Lo-Ciganic W-H, Park H. Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism. Am J Health Syst Pharm. 2020;77(3):188–195. doi:10.1093/ajhp/zxz307
  • Weycker D, Li X, Wygant GD, et al. Effectiveness and safety of apixaban versus warfarin as outpatient treatment of venous thromboembolism in U.S. clinical practice. Thromb Haemost. 2018;118(11):1951–1961. doi:10.1055/s-0038-1673689
  • Weycker D, Wygant GD, Guo JD, et al. Bleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses. Blood Adv. 2020;4(2):432–439. doi:10.1182/bloodadvances.2019001081
  • Al Ammari M, AlBalwi M, Sultana K, et al. The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort. Sci Rep. 2020;10(1):11613. doi:10.1038/s41598-020-68519-9
  • Ireland R. Warfarin bleeding risk increased in CKD. Nat Rev Nephrol. 2009;5(6):306. doi:10.1038/nrneph.2009.58
  • Hazlewood KA, Fugate SE, Harrison DL. Effect of oral corticosteroids on chronic warfarin therapy. Ann Pharmacother. 2006;40(12):2101–2106. doi:10.1345/aph.1H418
  • Anouassi Z, Atallah B, Alsoud LO, et al. Appropriateness of the direct oral anticoagulants dosing in the Middle East Gulf Region. J Cardiovasc Pharmacol. 2021;77(2):182–188. doi:10.1097/fjc.0000000000000913

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.